IRIS
VENEZIANI, BIANCA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.923
EU - Europa 2.753
NA - Nord America 2.547
SA - Sud America 378
AF - Africa 74
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.679
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.408
SG - Singapore 1.672
RU - Federazione Russa 1.173
IT - Italia 641
CN - Cina 627
BR - Brasile 326
HK - Hong Kong 284
DE - Germania 200
VN - Vietnam 172
FI - Finlandia 147
FR - Francia 136
NL - Olanda 114
IE - Irlanda 111
CA - Canada 100
UA - Ucraina 85
GB - Regno Unito 64
IN - India 52
CI - Costa d'Avorio 33
SE - Svezia 28
MX - Messico 27
AR - Argentina 24
BD - Bangladesh 22
ZA - Sudafrica 18
PL - Polonia 17
ID - Indonesia 13
JP - Giappone 13
IQ - Iraq 11
ES - Italia 9
CO - Colombia 7
KR - Corea 7
TR - Turchia 7
AT - Austria 6
EC - Ecuador 6
UZ - Uzbekistan 6
VE - Venezuela 6
LT - Lituania 5
PK - Pakistan 5
EG - Egitto 4
IR - Iran 4
NP - Nepal 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
BE - Belgio 3
CL - Cile 3
IL - Israele 3
MA - Marocco 3
MK - Macedonia 3
PA - Panama 3
PY - Paraguay 3
AU - Australia 2
DJ - Gibuti 2
DZ - Algeria 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PE - Perù 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LY - Libia 1
MN - Mongolia 1
MY - Malesia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 8.679
Salva come PNG Salva come JPEG
Città #
Singapore 731
Moscow 303
Hong Kong 284
Beijing 235
Chandler 209
Napoli 176
Ashburn 174
Santa Clara 122
Jacksonville 120
Princeton 112
Dallas 106
Amsterdam 103
Naples 102
Millbury 96
Nanjing 94
Boston 90
Ottawa 68
Los Angeles 65
Wilmington 63
Ho Chi Minh City 54
Munich 54
Hefei 50
The Dalles 46
Buffalo 43
Hanoi 39
Redondo Beach 39
São Paulo 30
New York 26
Nanchang 25
Des Moines 22
Falls Church 21
Hebei 21
Rome 21
Mexico City 20
Norwalk 20
Dublin 19
Tianjin 19
Turku 19
Woodbridge 19
Helsinki 17
Pune 16
Changsha 15
Montreal 15
Hicksville 14
Shenyang 14
Frankfurt am Main 13
Milan 13
Seattle 13
Tokyo 13
Dong Ket 12
London 12
Redwood City 12
Warsaw 12
Chicago 11
Stockholm 11
Haiphong 10
Palma Campania 10
Rio de Janeiro 10
Boardman 9
Brasília 9
Brooklyn 9
Chennai 9
Formia 9
Jiaxing 9
Nuremberg 9
Poplar 9
Ann Arbor 8
Denver 8
Houston 8
Manchester 8
Orem 8
San Mateo 8
Afragola 7
Belo Horizonte 7
Charlotte 7
Curitiba 7
Hangzhou 7
Kunming 7
Seoul 7
Toronto 7
Biên Hòa 6
Da Nang 6
Dhaka 6
Florence 6
Hải Dương 6
Kochi 6
Redmond 6
Salerno 6
Shanghai 6
Elk Grove Village 5
Guarulhos 5
Indiana 5
Phoenix 5
Portici 5
Porto Alegre 5
Tashkent 5
Ankara 4
Atlanta 4
Baghdad 4
Caserta 4
Totale 4.384
Salva come PNG Salva come JPEG
Nome #
Progetto dimostratore di analisi dei tessuti: BIONCAM BIObanca ONcologica CAMpania 251
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 177
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 150
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 144
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 142
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status 131
1599P - Effects of Hedgehog signaling inhibition on epithelial-stromal interactions in triple negative breast cancer cells 129
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex 121
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers 120
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. 117
Epidermal growth factor receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. 111
Exploring the molecular aspects associated with testicular germ cell tumors: A review 109
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells 108
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results 108
The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment 106
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models. 106
P0081 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib 106
Reti dinamiche di apprendimento a distanza 105
Tranfected Insulin- like growth factor II modulates the mitogenic response of rat thyrocytes in culture 103
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma. 103
Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. 102
Long-term cultures of stem/progenitor cells from lobular and ductal breastcarcinomas under non-adherent conditions. 102
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. 102
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review 100
Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2B 99
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. 98
A banking strategy toward customized therapy in breast cancer. 98
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 96
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. 95
The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer 93
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity 93
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 90
SPHINGOSINE KINASE 1 (SPHK1) CONTRIBUTES TO RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS IN COLORECTAL CANCER MODELS 90
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 88
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 87
AIRC Regional Grant ; “Breast cancer: preclinical and clinical development of therapeutic strategies targeting molecular mechanisms”. 86
Endogenous IGFs modulates the mitogenic response of rat thyrocites in culture. 86
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer 83
Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). 82
INHIBITION OF CANCER CELL GROWTH AND INVASION BY TARGETING C-SRC IN BREAST CANCER MODELS RESISTANT TO ANTI-HER2 DRUGS 81
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity. 79
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. 78
Expression of the soluble lectin L-14 gene is induced by TSH in thyroid cells and suppressed by retinoic acid in transformed neural cells. 78
Adenosine 3',5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells. 77
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. 76
Inibizione della proliferazione: ruolo del cAMP. 76
Iodine Inhibits the Proliferation of Rat-thyroid Cells In Culture 76
ALTERATIONS OF AUTOPHAGIC FLUX IN CHARCOT-MARIE-TOOTH 2B DISEASE 75
Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine. 73
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a 72
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 72
Endogenous IGFs modulate the mitogenic response in rat thyrocites in culture. 70
Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. 70
Micrornas in prostate cancer: an overview 70
Endogenous IGF-II as a possible regulator of fetal rat thyroid gland development. 69
Pharmacogenetics and Endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and Toxicity. 67
Circulating and disseminated tumor cells from breast cancer patient 67
Ruolo di fattori di crescita autocrini nel controllo della proliferazione di cellule di tiroide di ratto in coltura. 66
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase 66
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes 66
Independent and Interactive Effects of Tetradecanoyl Phorbol Acetate On Growth and Differentiated Functions of Frtl5 Cells 65
“Pharmacogenetics and endocrine therapy in postmenopausal early breast cancer patients. Correlation study of gene CYP19 and CYP2D6 polymorphisms with efficacy and toxicity” 64
ADE-SOCRATES- Sperimentazione di e-learning su un corso di Attività Didattica Elettiva della Facoltà di Medicina e Chirurgia di Napoli “Federico II”. In: Reti dinamiche di apprendimento a distanza, U. Giani ed. Liguori Editore, pp. 345-350, 2004. ISBN: 88-207-3637-3 62
Principi di Patologia Generale 61
Condroitin-6-sulfate carbohydrate units. A major source of molecular microheterogeneity of human thyroglobulin. 61
Growth control of follicular cells in vitro. 61
In the thyroid cells proliferation, differentiated and metabolic functions are under the control of different steps of the cyclic AMP cascade. 60
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 59
Evidence of a biological role of an endogenous growth factor on the proliferation of rat thyroid cells. 59
IGF endogeno e proliferazione di tireociti. 59
Adenosine Has Divergent Effects On Deoxyribonucleic-acid Synthesis In Frtl5 Cells - Inhibition of Thyrotropin-stimulated and Potentiation of Insulin-like Growth Factor-i-stimulated Thymidine Incorporation 59
Dissociation and reassociation of non-covalently linked dimers of human 19S thyroglobulin treated with urea. 58
The disulfide bond pattern between fragments obtained by the limited proteolysis of bovine thyroglobulin. 58
TSH-EGF cooperation in the FRTL5 thyroid cell growth stimulation. 58
Annual Meeting of the ECTS Medical Association 57
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. 56
Iodine inhibits the proliferation of rat thyroid cells in culture. 55
On the role of iodine on the proliferation of FRTL5 cells. 55
Oncotech 55
Expression of the Soluble Lectin L-14 Gene Is Induced By Tsh In Thyroid-cells and Suppressed By Retinoic Acid In Transformed Neural Cells 55
SRC INHIBITORS ACT THROUGH DIFFERENT MECHANISMS TO COOPERATE WITH EGFR OR MEK INHIBITORS IN NSCLC MODELS SENSITIVE OR RESISTANT TO ERLOTINIB 55
In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches. 53
Iodine inhibits the proliferation of rat thyroid cells in culture. 53
Expression of genes related to cell cycle in thyroid cells in culture. 53
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review 53
Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. 52
The tissue-specific pathways regulating cell proliferation are inherited independently in somatic hybrid between thyroid and liver cells. 52
Realizzazione e potenziamento di laboratori pubblici nei settori delle "scienze della nutrizione", "chirurgia avanzata" e "analisi dei tessuti". 51
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water 51
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences 51
Elevated intracellular concentrations of cAMP act as a negative modulator of thyroid cell proliferation. 50
Transfected insulin-like growth factor II modulates the mitogenic response of rat thyrocytes in culture. 50
Independent and interactive effects of tetradecanoyl phorbol acetate on growth and differentiated functions of FRTL5 cells. 50
Short-term and Long-term Effects of Egf On Frtl5 Cells Growth 50
Sustained versus transient cyclic AMP intracellular levels: effect on thyrotropin-dependent growth of thyroid cells. 49
Studio GIM5: Studio di correlazione tra il gene CYP19 e l’efficacia di Letrozolo in pazienti in postmenopausa con tumore della mammella 48
Sustained versus transient cyclic AMP intracellular levels: Effect on thyrotropin-dependent growth of thyroid cells 48
Adenosine has divergent effects on deoxyribonucleic acid synthesis in FRTL5 cells: inhibition of thyrotropin-stimulated and potentiation of insulin-like growth factor-I-stimulated thymidine incorporation. 47
Iodine inhibits thyroid cell proliferation through a cAMP-independent mechanism. 47
Epithelial-mesenchymal transition in prostate cancer: an overview 46
Totale 8.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.907
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 40 19 19 52 13 46 20
2021/2022701 11 0 6 12 28 23 22 29 117 55 116 282
2022/2023605 124 43 20 23 65 60 2 51 72 106 28 11
2023/2024475 17 58 72 38 32 56 4 41 1 5 101 50
2024/20252.774 154 167 9 52 58 128 332 136 263 306 954 215
2025/20262.837 615 374 428 379 839 202 0 0 0 0 0 0
Totale 8.829